Resmed Inc. buy UBS Group AG
Start price
12.12.25
/
50%
€214.10
Target price
12.12.26
-
Performance (%)
3.64%
Price
21.01.26
€221.90
Summary
This prediction is currently active. With a performance of 3.64%, the BUY prediction by UBS_Group_AG for Resmed Inc. is trending in the right direction. This prediction currently runs until 12.12.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -0.493% | -0.493% |
| iShares Core DAX® | -1.933% | 2.239% |
| iShares Nasdaq 100 | -0.972% | 0.226% |
| iShares Nikkei 225® | -2.056% | 5.685% |
| iShares S&P 500 | -1.185% | 0.867% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for RMD provided by MarketBeat